A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Clinical trial NCT06594393 · RECRUITING

Trial details

NCT number: NCT06594393
Sponsor: Xinnate AB
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa Junctional Epidermolysis Bullosa

Start date: 2026-01-30
Primary completion: 2027-06-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.